Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding XBI?
Track your performance easily
XBI Price & Analysis
XBI ETF Chart & Stats
Day’s Range― - ―
52-Week Range$68.31 - $92.60
Previous Close$70.3
VolumeN/A
Average Volume (3M)7.57M
AUM5.16B
NAV70.28
Expense Ratio0.35%
Holdings Count135
Beta1.04
Inception DateJan 31, 2006
Last Dividend Ex-Date
Jun 20, 2023Dividend Yield
<0.01 (―)Shares Outstanding78,900,000
Standard Deviation0.08
10 Day Avg. Volume10,897,805
30 Day Avg. Volume7,574,165
Alpha-0.00858
XBI ETF News
XBI ETF FAQ
What was XBI’s price range in the past 12 months?
XBI lowest ETF price was $68.31 and its highest was $92.60 in the past 12 months.
What is the AUM of XBI?
As of Oct 17, 2023 The AUM of XBI is 5.16B.
Is XBI overvalued?
According to Wall Street analysts XBI’s price is currently Undervalued.
Does XBI pay dividends?
XBI pays a Notavailable dividend of <$0.01 which represents an annual dividend yield of N/A. See more information on XBI dividends here
How many shares outstanding does XBI have?
XBI has 78,900,000 shares outstanding.
Which hedge fund is a major shareholder of XBI?
Among the largest hedge funds holding XBI’s share is Sivik Global Healthcare LLC. It holds XBI’s shares valued at 21M.
XBI ETF Smart Score
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Mirati Therapeutics
2.23%
Immunovant, Inc.
1.67%
Ionis Pharmaceuticals Inc.
1.59%
Amgen Inc
1.56%
Vertex Pharmaceuticals Inc.
1.52%
Apellis Pharmaceuticals
1.50%
Seagen Inc.
1.49%
United Therapeutics Corp.
1.46%
Neurocrine Biosciences
1.44%
Regeneron Pharmaceuticals
1.43%
Total15.88%
ETF Description
SPDR S&P BIOTECH ETF
XBI tracks an equal-weighted index of US biotechnology stocks.